alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. 

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, Spore in Breast Cancer.                     

*Date:*                         February 8-10, 2005.                     

*Time:*                         8 a.m. to 5 p.m..                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Hilton Washington 1919 Connecticut Avenue, NW., Washington, DC 20009.                     

*Contact Person:*                         Shamala K. Srinivas, PhD., Scientific Review Administrator, Grants Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8133, Bethesda, MD 20892; (301) 594-1224.                     

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) 

Dated: November 30, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory Committee Policy. 

[FR Doc. 04-26895  Filed 12-7-04; 8:45 am] 

BILLING CODE 4140-01-M
Part 520 [Reserved]           **Parent topic:** General Services Administration Acquisition Manual
MP5301.9001i2viA (A) Procedures.

(1) The Clearance Approval Authority (CAA) is responsible for tailoring the documentation needs,

briefing requirements, and review processes to fit each action subject to clearance approval.

Guidelines to inform the CAA’s decisions regarding procedures are presented below. The contracting

officer shall consult with the CAA early in the acquisition process to determine the documentation,

briefing, and review expectations.

(a) Documentation and Briefing. The magnitude, complexity, and risk of the proposed action should

govern the documentation and briefing requirements. The contract file must document the

Clearance approval and identify the information relied upon in making the Clearance decision.

(b) Review. The magnitude, complexity, and risk of the proposed action should also inform review

procedures (e.g., timing and duration of review, review team members, documentation to be

reviewed, expected output from the review team). Clearance review provides an independent

examination of the proposed action and may be conducted by the CAA or an independent advisor to

the CAA. Clearance review at the SCO level is typically performed by SSC/PKV with support from

SSC/PKF and SSC/JAQ. In some circumstances, inclusion of representatives from other functional

organizations (e.g., SSC/FM, SSC/SB) may be beneficial.

(c) When a DoD Peer Review is required, Clearance should ordinarily be conducted prior to the Peer

Review and Clearance approval should be made contingent on Peer Review results unless the

Clearance Approval Authority directs otherwise

Parent topic: MP5301.9001i2vi - Clearance Approval when the HCA is SSC/PK Director
Exhibit 32.1
 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  (a)
    
    the Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and(b)
    
    the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 Date: May 14, 2008
    By:
    /s/ Glenn M. Parker, M.D.Glenn M. Parker, M.D.Chief Executive Officer
(Principal Executive Officer)Date: May 14, 2008
    By:
    /s/ Timothy FairbanksTimothy FairbanksChief Financial Officer
(Principal Financial Officer)
<PAGE>

                                  EXHIBIT 10.2

                              AMENDMENT NO. 2005-1
                                     TO THE
                    RETIREMENT PLAN FOR SALARIED EMPLOYEES OF
                            ARROW INTERNATIONAL, INC.


        WHEREAS, Arrow International, Inc. (the "Employer") sponsors and
maintains the Retirement Plan for Salaried Employees of Arrow International,
Inc. (the "Plan"); and

        WHEREAS, the Employer has reserved the right to amend the Plan at any
time pursuant to Section 10.1 of the Plan; and

        WHEREAS, the Employer desires to amend the Plan to comply with the
provisions of section 401(a)(31)(B) of the Internal Revenue Code of 1986, as
amended;

        NOW, THEREFORE, the Plan is hereby amended as follows:

        1.      Sections 6.3, 7.8(a), 7.8(b), 7.8(d) and H.2(a)(4) of the Plan
are hereby amended by replacing "$5,000" with "$1,000."

        IN WITNESS WHEREOF, ARROW INTERNATIONAL, INC. has caused this Amendment
No. 2005-1 to the Plan to be duly executed this ________ day of
___________________________, 2005.


ATTEST:                                 ARROW INTERNATIONAL, INC.



__________________________________      By:_____________________________________
#### Hugo Kastor, Appellant-Respondent, v. Andrew G. W. Frederick, Doing Business as Frederick Mahogany Company, Respondent-Appellant.

Present — Foster, P. J., Heffeman, Brewster, Deyo and Santry, JJ.
§ 210.2-07 Communication with audit committees. ( a ) Each registered public accounting firm that performs for an audit client that is an issuer (as defined in section 10A(f) of the Securities Exchange Act of 1934 (15 U.S.C. 78j-1(f))), other than an issuer that is an Asset-Backed Issuer as defined in § 229.1101 of this chapter, or an investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8), other than a unit investment trust as defined by section 4(2) of the Investment Company Act of 1940 (15 U.S.C. 80a-4(2)), any audit required under the securities laws shall report, prior to the filing of such audit report with the Commission (or in the case of a registered investment company, annually, and if the annual communication is not within 90 days prior to the filing, provide an update, in the 90 day period prior to the filing, of any changes to the previously reported information), to the audit committee of the issuer or registered investment company: ( 1 ) All critical accounting policies and practices to be used;
( 2 ) All alternative treatments within Generally Accepted Accounting Principles for policies and practices related to material items that have been discussed with management of the issuer or registered investment company, including: ( i ) Ramifications of the use of such alternative disclosures and treatments; and
( ii ) The treatment preferred by the registered public accounting firm;
( 3 ) Other material written communications between the registered public accounting firm and the management of the issuer or registered investment company, such as any management letter or schedule of unadjusted differences;
( 4 ) If the audit client is an investment company, all non-audit services provided to any entity in an investment company complex, as defined in § 210.2-01 (f)(14), that were not pre-approved by the registered investment company's audit committee pursuant to § 210.2-01 (c)(7).
( b ) [Reserved]
[68 FR 6048, Feb. 5, 2003, as amended at 70 FR 1593, Jan. 7, 2005]
Exhibit 12



                    THE COASTAL CORPORATION AND SUBSIDIARIES
                COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES


<TABLE>
<CAPTION>
                                                                                                 Nine Months Ended
                                                       Year Ended December 31,                     September 30,   
                                         --------------------------------------------------    --------------------
                                           1993       1994       1995       1996       1997       1997       1998  
                                         --------   --------   --------   --------   --------   --------   --------
                                                        (Dollars in Millions)
<S>                                     <C>        <C>        <C>        <C>        <C>        <C>        <C>      
EARNINGS:
  Pretax earnings from continuing
    operations........................  $  202.4   $  324.9   $  297.2   $  645.1   $  509.1   $  360.1   $  418.7
  Fixed charges, excluding capitalized
    interest - see below..............     481.8      433.9      441.9      399.2      348.4      261.1      262.3
                                        --------   --------   --------   --------   --------   --------   --------
     Earnings.........................  $  684.2   $  758.8   $  739.1   $1,044.3   $  857.5   $  621.2   $  681.0
                                        ========   ========   ========   ========   ========   ========   ========

FIXED CHARGES:
  Interest expense....................  $  442.5   $  407.8   $  415.4   $  368.3   $  307.5   $  230.3   $  221.2
  Interest factor, included in rentals      32.7       24.0       26.5       30.9       31.7       23.5       21.1
  Dividends on preferred stock of
    subsidiaries......................       6.6        2.1          -          -        9.2        7.3       20.0
                                        --------   --------   --------   --------   --------   --------   --------

  Fixed charges, excluding capitalized
    interest..........................     481.8      433.9      441.9      399.2      348.4      261.1      262.3
  Capitalized interest................       8.4        8.3        5.9        8.0       15.5        7.1       18.5
                                        --------   --------   --------   --------   --------   --------   --------
  Fixed charges.......................  $  490.2   $  442.2   $  447.8   $  407.2   $  363.9   $  268.2   $  280.8
                                        ========   ========   ========   ========   ========   ========   ========

Ratio of Earnings to Fixed Charges....     1.40x      1.72x   $  1.65x      2.56x      2.36x      2.32x      2.43x
                                        =======    =======    =======    =======    =======    =======    =======


</TABLE>
----

**EXHIBIT      32.2**

**CERTIFICATION      OF**

**CHIEF      EXECUTIVE OFFICER**

**PURSUANT      TO**

**18      U.S.C. SECTION 1350**

| (1) | the                Quarterly Report on Form 10-QSB of the Company for the quarter ended                March                31, 2006 as filed on the date hereof with the Securities and Exchange                Commission (the "Report") fully complies with the requirements of                Section                13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;                and |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   |
|--------|--------|
| (2) | the                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:                May 15, 2006      |   |
|----------------------------------------|--------|
|                                   |   |
|                                   |   |
| /s/                Ted T.H. Jeong      |   |
| Ted                T.H. Jeong          |
| Chief                Financial Officer |

----
#### Julius Crossman v. W. Whitman Company.

Application denied, with ten dollars costs. Order signed. Present—Clarke, P. J., Laughlin, Dowling, Smith and Davis, JJ.
exv10w4



 





Exhibit 10.4



AMENDMENT TO S-76 NEW HELICOPTER SALES AGREEMENT



THIS AMENDMENT, dated as of the Acceptance Date stated below, by and between the Sikorsky
Contracting Entity (“Sikorsky”) named below and the Buyer named below, hereby amends the S-76 New
Helicopter Sales Agreement between the parties as follows:




     1. Definitions/Information for this Amendment



	 	 	 
	Buyer:

	 	Offshore Logistics, Inc.
	Sikorsky Contracting Entity:

	 	Sikorsky Aircraft Corporation
	Sikorsky Contract No.:

	 	S76TD02065
	Amendment No.:

	 	3






     2. Amendment — Amend the S-76 Sales Agreements as follows:



     A. Configuration



     Revised Exhibit A, FOR THE 2004-2008 AIRCRAFT ONLY, as follows:



     1. Add 6086 Collective guards.



     2. Add 8660 Rotor Pedals Lube Kit



     3. Add 9009 Vertical Pylon Access Panels, CSN-76-207



     4. Add 9011 Three (3) Corrosion Inspection Holes



     5. Add 8876 Cyclic Stick Position Guard



     6. Add 8301 Annuciator “Fuel Transfer Feed On”.



     7. Delete 9014 Meggitt Avionics CVR: SC500-120



     8. Add 9021 L3 CVR (replaces Meggitt SCR500-120)



     9. Add 9016: Life Vest Pouches (remove from fuel deck).



     10. Add 9017: Boarding Card Stowage on ERDA Seats.



     11. Add 9018: Covers and Drains on Flight Manual Holders.



     12. Add 9019: Delete Floor Cover and Add Non-Skid.



     13. Add 9020 Mobile 291 Engine Oil



     14. Add 9002 HUMS provisions (wire harness/shelving)



     B. Payment Schedule



     Delete Section III.1. Table 1 and substitute with the following:



TABLE 1

Payment Schedule




*




     C. Aircraft Price



     Delete Section III.2. Table 2 and substitute with the following:



TABLE 2

Helicopter Unit Price




*




     Payments and prices changes in Item B and C Tables above reflect credit to the
Buyer as a result of specified configuration changes.




	3.	 	Reaffirmation — Except as modified above, all of the provisions of
the Agreement remain the same, and the Agreement as modified hereby,
is reaffirmed.





     IN WITNESS WHEREOF, this Amendment has been executed by each party’s authorized
representative.



	 	 	 
	Offshore Logistics, Inc.:

	 	Sikorsky Aircraft Corporation:
	By: /s/ Drury A. Milke

	 	By: /s/ Mick Maurer
	Name: Drury A. Milke

	 	Name: Mick Maurer
	Title: Executive Vice President

	 	Title: Vice President — Commercial Programs
	Date: January 20, 2004

	 	Date: January 22, 2004
§ 680.24 Reasonable opportunity to opt out. ( a ) *In general.* You must not use eligibility information about a consumer that you receive from an affiliate to make a solicitation to the consumer about your products or services, unless the consumer is provided a reasonable opportunity to opt out, as required by § 680.21(a)(1)(ii) of this part.
( b ) *Examples of a reasonable opportunity to opt out.* The consumer is given a reasonable opportunity to opt out if: ( 1 ) *By mail.* The opt-out notice is mailed to the consumer. The consumer is given 30 days from the date the notice is mailed to elect to opt out by any reasonable means.
( 2 ) *By electronic means.* ( i ) The opt-out notice is provided electronically to the consumer, such as by posting the notice at an Internet Web site at which the consumer has obtained a product or service. The consumer acknowledges receipt of the electronic notice. The consumer is given 30 days after the date the consumer acknowledges receipt to elect to opt out by any reasonable means.
( ii ) The opt-out notice is provided to the consumer by e-mail where the consumer has agreed to receive disclosures by e-mail from the person sending the notice. The consumer is given 30 days after the e-mail is sent to elect to opt out by any reasonable means.
( 3 ) *At the time of an electronic transaction.* The opt-out notice is provided to the consumer at the time of an electronic transaction, such as a transaction conducted on an Internet Web site. The consumer is required to decide, as a necessary part of proceeding with the transaction, whether to opt out before completing the transaction. There is a simple process that the consumer may use to opt out at that time using the same mechanism through which the transaction is conducted.
( 4 ) *At the time of an in-person transaction.* The opt-out notice is provided to the consumer in writing at the time of an in-person transaction. The consumer is required to decide, as a necessary part of proceeding with the transaction, whether to opt out before completing the transaction, and is not permitted to complete the transaction without making a choice. There is a simple process that the consumer may use during the course of the in-person transaction to opt out, such as completing a form that requires consumers to write a “yes” or “no” to indicate their opt-out preference or that requires the consumer to check one of two blank check boxes—one that allows consumers to indicate that they want to opt out and one that allows consumers to indicate that they do not want to opt out.
( 5 ) *By including in a privacy notice.* The opt-out notice is included in a Gramm-Leach-Bliley Act privacy notice. The consumer is allowed to exercise the opt-out within a reasonable period of time and in the same manner as the opt-out under that privacy notice.
###### Editorial Note on Part 240

#### Editorial Note:

Nomenclature changes to part 240 appear at 57 FR 36501, Aug. 13, 1992, and 57 FR 47409, Oct. 16, 1992.

#### § 240.16a-13 Change in form of beneficial ownership.

A transaction, other than the exercise or conversion of a derivative security or deposit into or withdrawal from a voting trust, that effects only a change in the form of beneficial ownership without changing a person's pecuniary interest in the subject equity securities shall be exempt from section 16 of the Act.

[61 FR 30393, June 14, 1996]
###### Editorial Note on Part 240

#### Editorial Note:

Nomenclature changes to part 240 appear at 57 FR 36501, Aug. 13, 1992, and 57 FR 47409, Oct. 16, 1992.

#### § 240.14n-3 Dissemination.

One copy of Schedule 14N (§ 240.14n-101) filed pursuant to §§ 240.14n-1 and 240.14n-2 shall be mailed by registered or certified mail or electronically transmitted to the registrant at its principal executive office. Three copies of the material must at the same time be filed with, or mailed for filing to, each national securities exchange upon which any class of securities of the registrant is listed and registered.

[75 FR 56788, Sept. 16, 2010]
#### Jacob A. Ulanov, Respondent, v. Eva V. C. Hawkes, Appellant, Impleaded with Another.

Order reversed, with ten dollars costs and dis*885bursements, and motion granted, with ten dollars costs. No opinion. Present—Clarke, P. J., McLaughlin, Scott, Dowling and Smith, JJ.
### §1962d–1. Rules and regulations

The Council is authorized to make such rules and regulations as it may deem necessary or appropriate for carrying out those provisions of this chapter which are administered by it.

(Pub. L. 89–80, title IV, §402, July 22, 1965, 79 Stat. 254.)
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 38 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                 H. R. 38

     To rescind funds appropriated to the Health Insurance Reform 
Implementation Fund under the Health Care and Education Reconciliation 
                              Act of 2010.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 5, 2011

 Mr. Fleming introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
     To rescind funds appropriated to the Health Insurance Reform 
Implementation Fund under the Health Care and Education Reconciliation 
                              Act of 2010.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. RESCISSION OF HEALTH INSURANCE REFORM IMPLEMENTATION FUNDS.

    The unobligated balance of funds made available by section 1005(b) 
of the Health Care and Education Reconciliation Act of 2010 (Public Law 
111-152; 42 U.S.C. 18121(b)) is hereby rescinded.
                                 <all>
```
EXHIBIT 35.1





World Omni Financial Corp.

Servicer Compliance Statement

Pursuant to Item 1123

of Regulation AB







I, Joseph A. Venezia,
do hereby certify that I am the Chief Financial Officer of World Omni Financial Corp., a Florida corporation, and further certify
on behalf of World Omni Financial Corp. in its capacity as servicer (the “Servicer”) under the Sale and Servicing Agreement,
dated as of November 14, 2019 (the “Agreement”), among World Omni Auto Receivables Trust 2019-C, as Issuing Entity,
World Omni Auto Receivables LLC, as Depositor, and the Servicer, as follows:



(i)A review of the activities of the Servicer during the period covered by the issuing entity’s Annual Report on form
10-K for the fiscal year ended December 31, 2019 (the “Reporting Period”), and of its performance under the Agreement,
has been made under my supervision.



(ii)To the best of my knowledge, based on the review described above, the Servicer has fulfilled all of its obligations under
the Agreement in all material respects throughout the Reporting Period.



IN WITNESS WHEREOF, I have hereunto
set my hand as of March 6, 2020.





| | WORLD
OMNI FINANCIAL CORP.





By:
/s/Joseph Venezia

Name:
Joseph Venezia

Title:
Chief Financial Officer
| | -----------------------------------------------------------------------------------------------------------
| |                                                                                                            
| |                                                                                                            
| |                                                                                                            
| |
#### Isobel G. Morgan, Appellant, v. Henry Von O. Morgan, Respondent.

No opinion. Present — Glennon, J. P., Dore, Cohn, Callahan and Shientag, JJ.